A statement by the editors of the Lancet

Lancet

Volumn 363, Issue 9411, 2004, Pages 820-821

  Horton, Richard ^a   Murch, Simon ^b   Walker Smith, John ^c   Wakefield, Andrew ^d   Hodgson, Humphrey ^b  

^a THE LANCET   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL ETHICS; MEDICAL LITERATURE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RESEARCH ETHICS; REVIEW;

EID: 1542345667     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15699-7     Document Type: Review

References (3)

1. Wakefield AJ Murch SH Anthony A Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351 1998 637 641
2. In 1998, The Lancet required that: “The Editor needs to be informed [of any conflicts of interest] and will discuss with you [the authors] whether or not disclosure in the journal is necessary. All sources of funding must be disclosed, as an acknowledgment in the text.”
3. See http://www.publicationethics.org.uk/cope1999/gpp/dealing.phtml